Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Pavlakis

Showing results (261-270 of 294) with videos related to

Pageof 30
Sort By:
The Lancet Regional Health. Europe|January 10, 2022
The benefits, costs and feasibility of a low incidence COVID-19 strategyThomas Czypionka, Emil N Iftekhar, Barbara Prainsack, et al.
JCI Insight|August 1, 2024
Focusing HIV-1 Gag T cell responses to highly conserved regions by DNA vaccination in HVTN 119Spyros A Kalams, Barbara K Felber, James I Mullins, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 2009
Differential association of programmed death-1 and CD57 with ex vivo survival of CD8+ T cells in HIV infectionConstantinos Petrovas, Benjamin Chaon, David R Ambrozak, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2005
Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell helpMichele A Kutzler, Tara M Robinson, Michael A Chattergoon, et al.
British Journal of Cancer|April 14, 2015
Cytokine profiling of docetaxel-resistant castration-resistant prostate cancerK L Mahon, H-M Lin, L Castillo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2025
Alectinib versus crizotinib in previously untreated ALK-positive advanced non-small cell lung cancer: final overall survival analysis of the phase III ALEX studyS Peters, R Camidge, R Dziadziuszko, et al.
Plos One|April 5, 2013
HIV-1 p24(gag) derived conserved element DNA vaccine increases the breadth of immune response in miceViraj Kulkarni, Margherita Rosati, Antonio Valentin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2015
A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trialA Davidson, A-S Veillard, A Tognela, et al.
Plos One|January 13, 2012
CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV controlBeatriz Mothe, Anuska Llano, Javier Ibarrondo, et al.
Human Vaccines & Immunotherapeutics|July 2, 2013
Comparison of intradermal and intramuscular delivery followed by in vivo electroporation of SIV Env DNA in macaquesViraj Kulkarni, Margherita Rosati, Jenifer Bear, et al.
Pageof 30

Showing results (261-270 of 294) with videos related to

Sort By:
Pageof 30
The Lancet Regional Health. Europe|January 10, 2022
The benefits, costs and feasibility of a low incidence COVID-19 strategyThomas Czypionka, Emil N Iftekhar, Barbara Prainsack, et al.
JCI Insight|August 1, 2024
Focusing HIV-1 Gag T cell responses to highly conserved regions by DNA vaccination in HVTN 119Spyros A Kalams, Barbara K Felber, James I Mullins, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 2009
Differential association of programmed death-1 and CD57 with ex vivo survival of CD8+ T cells in HIV infectionConstantinos Petrovas, Benjamin Chaon, David R Ambrozak, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2005
Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell helpMichele A Kutzler, Tara M Robinson, Michael A Chattergoon, et al.
British Journal of Cancer|April 14, 2015
Cytokine profiling of docetaxel-resistant castration-resistant prostate cancerK L Mahon, H-M Lin, L Castillo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2025
Alectinib versus crizotinib in previously untreated ALK-positive advanced non-small cell lung cancer: final overall survival analysis of the phase III ALEX studyS Peters, R Camidge, R Dziadziuszko, et al.
Plos One|April 5, 2013
HIV-1 p24(gag) derived conserved element DNA vaccine increases the breadth of immune response in miceViraj Kulkarni, Margherita Rosati, Antonio Valentin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 9, 2015
A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trialA Davidson, A-S Veillard, A Tognela, et al.
Plos One|January 13, 2012
CTL responses of high functional avidity and broad variant cross-reactivity are associated with HIV controlBeatriz Mothe, Anuska Llano, Javier Ibarrondo, et al.
Human Vaccines & Immunotherapeutics|July 2, 2013
Comparison of intradermal and intramuscular delivery followed by in vivo electroporation of SIV Env DNA in macaquesViraj Kulkarni, Margherita Rosati, Jenifer Bear, et al.
Pageof 30